Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome
Recent clinical studies have suggested that women with polycystic ovarian syndrome (PCOS) may have disturbances of growth hormone (GH) kinetics and the GH/insulin-like growth factor (IGF)-I system. The knowledge that in various metabolic abnormalities there is a paradoxical sensitivity of pituitary somatotrophs to thyrotrophin-releasing hormone (TRH) administration led to this investigation of the GH secretory response to TRH in women with PCOS, Twenty-four women with PCOS and 18 control women were studied. TRH was given as a single i.v. injection (time 0) and blood samples for GH measurements were obtained at -15, 0, 15, 30, 60 and 90 min. The GH responses were expressed as the area under the curve (AUC) or the differences from the basal value (Delta max), The GH response to TRH(mean +/- SEM) was greater in women with PCOS (Delta max 2.47 +/- 1.73 versus 0.47 +/- 0.06 ng/ml, P < 0.05 and GH AUC 8.05 +/- 2.10 versus 2.58 +/- 0.18 ng/ ml/90 min, P < 0.05), According to GH response to TRH, two PCOS subgroups were identified: (i) normal responders (n = 14) who showed Delta max GH response (0.36 +/- 0.06 ng/ml)and GH AUC (1.93 +/- 0.64 ng/ml/90 min) similar to that in the controls and (ii) over-responders (n +/- 10) who showed a paradoxical increase in GH concentrations in response to TRH Delta max GH response 5.43 +/- 1.27 ng/ml and GH AUC 16.62 +/- 3.51 ng/ml per 90 min) that was significantly higher than in normally responding PCOS patients (P < 0.0001) or in controls (P < 0.0001), These data demonstrate an enhanced GH response to TRH administration in a subgroup of women with PCOS.
Showing items related by title, author, creator and subject.
Vamvakopoulos, N. C. (1996)Following a brief introduction to the Biology (structure-function) of the steroid hormone receptor superfamily, an updated summary of pathogenic mutations in the steroid, thyroid hormone and vitamin D receptors causing ...
Growth hormone response to submaximal doses of ghrelin remains unchanged during the follicular phase of the cycle Messini, C. I.; Dafopoulos, K.; Malandri, M.; Georgoulias, P.; Anifandis, G.; Messinis, I. E. (2013)Background: Previous data have shown that ghrelin-induced growth hormone (GH) secretion is augmented in women by exogenous but not by endogenous estrogens. The purpose of this study was to examine the response of GH to ...
Pappa, A.; Seferiadis, K.; Fotsis, T.; Shevchenko, A.; Marselos, M.; Tsolas, O.; E.messinis, I. (1999)Gonadotrophin surge attenuating factor (GnSAF) is a new non-steroidal ovarian substance, different from inhibin, which attenuates the pre-ovulatory luteinizing hormone (LH) surge in superovulated women. Human follicular ...